Textbook of Lifestyle Medicine. Labros S. Sidossis

Чтение книги онлайн.

Читать онлайн книгу Textbook of Lifestyle Medicine - Labros S. Sidossis страница 14

Textbook of Lifestyle Medicine - Labros S. Sidossis

Скачать книгу

in turn, can influence the predisposition to some chronic diseases.

      Obesity is the consequence of a long‐term energy imbalance, whereby energy intake is higher than energy expenditure. A dramatic change in the way people consume food, ingest drinks, and move has been recorded during the past decades. A significant increase in the consumption of energy‐dense foods and simple sugars has been recorded worldwide. At the same time physical activity has decreased, due to the sedentary character of the working environment, changes in transportation, and urbanization. Moreover, short sleep duration (i.e., less than 7 hours/day) has been associated with an increase in BMI and the risk for developing obesity. Hormonal changes seen with sleep deprivation could potentially increase food intake and contribute to weight gain. The increase of the glucocorticoid stress hormone cortisol may also play a role in the development of obesity by increasing the appetite with a preference for energy‐dense foods (“comfort food”).

       Key Point

      Obesity is the consequence of a long-term energy imbalance, whereby energy intake is higher than energy expenditure.

      Source: Popkin et al. (2012).

Biology Technology
Sweet preferences Cheap caloric beverage revolution
Thirst and hunger/satiety mechanisms not linked Caloric beverage revolution
Fatty food preference Edible oil revolution – high‐yield oilseeds, cheap removal of oils
Desire to eliminate exertion Technology in all phases of movement/exertion

      CVDs include ischemic heart disease (IHD), stroke, heart failure and peripheral arterial disease, and a number of cardiac and vascular conditions, such as cerebrovascular disease, rheumatic heart disease, and congenital heart disease. It has been estimated that heart attacks and strokes account for over 85% of CVD death events. The events themselves are generally acute in nature and result from an obstruction of blood flow to the heart or brain due to the chronic accumulation of lipid deposition on the inner walls of the blood vessels. In addition, strokes can also occur as a consequence of a brain blood vessel bleeding or because of the presence of blood clots.

      CVDs have emerged as the primary cause of death around the globe. According to the 2019 Heart Disease and Stroke Statistics report from the American Heart Association, someone dies of CVD every 38 seconds. Nearly 80% of premature deaths, i.e., death events among people under 70 years old, have been recorded in low‐to‐middle‐income countries, with 37% being attributed to CVDs. Underdeveloped or developing countries suffer high rates of CVD mortality, whereas high‐income industrialized countries and some regions in Latin America show the lowest CVD mortality.

       Key Point

      CVD burden can be attributed to modifiable risk factors such as diet, exercise, tobacco smoking, obesity, hypertension, dyslipidemia, diabetes mellitus, and alcohol consumption.

      According to the WHO, diabetes mellitus is defined as “a metabolic disorder of multiple etiology, characterized by chronic hyperglycemia (high blood sugar) with disturbances of carbohydrate, fat, and protein metabolism resulting from defects in insulin secretion, insulin action, or both.” Diabetes mellitus is classified into type 1 (T1DM; insulin‐dependent) and type 2 diabetes mellitus (T2DM; non‐insulin‐dependent or adult‐onset). While the main feature of T1DM is the defective production of insulin (by the pancreas) and the requirement of daily administration of insulin, T2DM is characterized by inefficient use of insulin from the body.

      T1DM cannot be prevented, and we still do not fully understand what causes the disease. Furthermore, it is still under investigation whether environmental factors could trigger the destruction of the body's insulin‐producing cells. On the other hand, T2DM development and progression are affected by genetic and environmental factors; exposure to an obesogenic environment, characterized by sedentary behavior, increased stress, and excessive energy consumption, is known to exert an effect on preexisting genetic factors.

      The prevalence of T2DM has dramatically increased since the 1980s, affecting more than 430 million people, compared to 108 million about three decades ago. The increase in diabetes cases is more evident in low‐ to middle‐income countries. According to the World Health Organization, more than 1.5 million people worldwide died due to diabetes in 2019. The Centers for Disease Control and Prevention (CDC) estimated that almost 80.000 deaths occur each year due to diabetes in the United States. The WHO projects that by 2030, diabetes mellitus will be the seventh most important cause of mortality.

      Diabetes mellitus can progressively lead to a host of other metabolic abnormalities affecting the heart, blood vessels, eyes, kidneys, and nerves. It has been shown that individuals suffering from diabetes mellitus have two to three times higher risk for developing CVDs compared to their nondiabetic counterparts. Furthermore, reduced blood flow and nerve damage (i.e., neuropathy) in the lower extremities can substantially exaggerate the occurrence of foot ulcers and infection, even leading to amputation of the lower limbs. Chronic impairments in the small blood vessels of the retina (i.e., retinopathy) can gradually lead to blindness; approximately 3% of all blindness cases worldwide could be attributed to diabetes. Finally, diabetes mellitus constitutes one of the major causes of renal failure.

       Key Point

      Diabetes mellitus can progressively lead to other metabolic abnormalities affecting the heart, blood vessels, eyes, kidneys, and nerves.

      Cancer covers a wide spectrum of diseases whose typical characteristic is abnormal cellular growth, exceeding the normal rate of cellular proliferation. Other

Скачать книгу